FHIR © HL7.org  |  Server Home  |  FHIR Server FHIR Server 3.9.0  |  FHIR Version n/a  User: [n/a]

10470411000001100: Mestinon retard 180mg tablets (Viatris UK Healthcare Ltd) (product)

Status: current, Not sufficiently defined by necessary conditions definition status. Date: 02-Oct 2006. Module: SNOMED CT United Kingdom drug extension module

Descriptions:

Id Description Lang Type Status Case? Module
226191000001111 Mestinon retard 180mg tablets (Mylan) en Synonym Inactive Entire term case sensitive SNOMED CT United Kingdom drug extension module
226201000001113 Mestinon retard 180mg tablets (Mylan) (product) en Fully specified name Inactive Entire term case sensitive SNOMED CT United Kingdom drug extension module
2114201000001112 Mestinon retard 180mg tablets (Viatris UK Healthcare Ltd) en Synonym Active Entire term case sensitive SNOMED CT United Kingdom drug extension module
2114221000001117 Mestinon retard 180mg tablets (Viatris UK Healthcare Ltd) (product) en Fully specified name Active Entire term case sensitive SNOMED CT United Kingdom drug extension module
35926301000001118 Mestinon retard 180mg modified-release tablets (Valeant Pharm) (product) en Fully specified name Inactive Entire term case sensitive SNOMED CT United Kingdom drug extension module
35926401000001114 Mestinon retard 180mg modified-release tablets (Valeant Pharm) en Synonym Inactive Entire term case sensitive SNOMED CT United Kingdom drug extension module
39746701000001115 Mestinon retard 180mg tablets (Valeant Pharm) en Synonym Inactive Entire term case sensitive SNOMED CT United Kingdom drug extension module
45488301000001112 Mestinon retard 180mg tablets (Valeant Pharmaceuticals Ltd) en Synonym Inactive Entire term case sensitive SNOMED CT United Kingdom drug extension module
54276601000001110 Mestinon retard 180mg tablets (Meda Pharmaceuticals Ltd) en Synonym Inactive Entire term case sensitive SNOMED CT United Kingdom drug extension module

0 descendants.

Expanded Value Set

Outbound Relationships Type Target Active Characteristic Refinability Group Values
Mestinon retard 180mg tablets (Viatris UK Healthcare Ltd) Has NHS dm+d (dictionary of medicines and devices) controlled drug category Controlled drug category No Controlled Drug Status true Inferred relationship Existential restriction modifier
Mestinon retard 180mg tablets (Viatris UK Healthcare Ltd) Has NHS dm+d (dictionary of medicines and devices) AMP (actual medicinal product) availability restriction indicator NHS dm+d (dictionary of medicines and devices) AMP (actual medicinal product) availability restriction individual patient supply true Inferred relationship Existential restriction modifier
Mestinon retard 180mg tablets (Viatris UK Healthcare Ltd) Is a Pyridostigmine bromide 180mg m/r tablet false Inferred relationship Existential restriction modifier
Mestinon retard 180mg tablets (Viatris UK Healthcare Ltd) Has active ingredient Pyridostigmine bromide true Inferred relationship Existential restriction modifier
Mestinon retard 180mg tablets (Viatris UK Healthcare Ltd) Has manufactured dose form Tablet false Inferred relationship Existential restriction modifier
Mestinon retard 180mg tablets (Viatris UK Healthcare Ltd) Has excipient Excipient not declared true Inferred relationship Existential restriction modifier
Mestinon retard 180mg tablets (Viatris UK Healthcare Ltd) VMP non-availability indicator Not available true Inferred relationship Existential restriction modifier
Mestinon retard 180mg tablets (Viatris UK Healthcare Ltd) VMP prescribing status (attribute) VMP valid as a prescribable product true Inferred relationship Existential restriction modifier
Mestinon retard 180mg tablets (Viatris UK Healthcare Ltd) VMP non-availability indicator Available false Inferred relationship Existential restriction modifier
Mestinon retard 180mg tablets (Viatris UK Healthcare Ltd) Is a Mestinon retard true Inferred relationship Existential restriction modifier
Mestinon retard 180mg tablets (Viatris UK Healthcare Ltd) Has specific active ingredient Pyridostigmine bromide true Inferred relationship Existential restriction modifier
Mestinon retard 180mg tablets (Viatris UK Healthcare Ltd) Has dispensed dose form Modified-release oral tablet true Inferred relationship Existential restriction modifier
Mestinon retard 180mg tablets (Viatris UK Healthcare Ltd) Has manufactured dose form Conventional release oral tablet true Inferred relationship Existential restriction modifier
Mestinon retard 180mg tablets (Viatris UK Healthcare Ltd) Is a Actual medicinal product true Inferred relationship Existential restriction modifier
Mestinon retard 180mg tablets (Viatris UK Healthcare Ltd) Is a Pyridostigmine bromide 180mg modified-release tablets false Inferred relationship Existential restriction modifier
Mestinon retard 180mg tablets (Viatris UK Healthcare Ltd) Is a Pyridostigmine bromide 180mg modified-release tablets true Inferred relationship Existential restriction modifier
Inbound Relationships Type Active Source Characteristic Refinability Group
Mestinon retard 180mg tablets (Viatris UK Healthcare Ltd) 100 tablet Is pack of False Mestinon retard 180mg tablets (Viatris UK Healthcare Ltd) Inferred relationship Existential restriction modifier
Mestinon retard 180mg tablets (Viatris UK Healthcare Ltd) 100 tablet Has AMP True Mestinon retard 180mg tablets (Viatris UK Healthcare Ltd) Inferred relationship Existential restriction modifier

This concept is not in any reference sets

Back to Start